Aaron Bujnowski is a Director with The Chartis Group and Integrated Delivery Network Leader. Aaron’s healthcare career spans over 15 years. He focuses on developing innovative enterprise strategies that enable integrated delivery networks and their leaders to create lasting competitive advantage. He also helps PE firms to effectively make buy- or sell-side decisions and deliver increased value through their portfolio companies.
Prior to joining Chartis, Aaron was the system Chief Strategy Officer at Texas Health Resources, where he spent nearly nine years. He was responsible for developing and implementing strategies across the entire enterprise, including acute, post-acute, ambulatory, physician, consumer, and value-based approaches. His experience also includes more than four years with the Boston Consulting Group (BCG), where he served as a core member of BCG's strategy and healthcare practices. He was also a founding member of BCG’s PE practice, spending time on Wallstreet working on deals with many of the country’s largest PE firms. Aaron previously held various leadership positions in new venture development and innovation at The Dow Chemical Company for more than nine years.
While at Chartis, Aaron has worked with large Integrated Delivery Networks (IDNs) on major strategic efforts, including enterprise strategy development and implementation, service line strategy and structure, consumer strategy, and strategic and community partnership development. He has also helped accelerate the growth of the PE practice, working on buy-side due diligence efforts and sell-side efforts in the health provider space. Leveraging his previous in-house strategy experience, he has also worked on value-enabling efforts for PE portfolio companies, which have resulted in identifying significant sources of organic and inorganic growth and operational efficiencies for his clients.
Aaron holds a Master of Business Administration from The University of Texas at Austin, where he graduated with the highest honors. He also holds a Bachelor’s and a Master’s degree in Chemical Engineering with a biomedical emphasis from Brigham Young University in Provo, Utah, where he graduated with honors. In 2015, Aaron became a Fellow of the American College of Healthcare Executives (FACHE).